Coronavirus Disease 2019 (COVID-19)

FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on August 26, 2020 include: Coronavirus (COVID-19) updates September 1, 2020: Daily Roundup - FDA’s action on a warning letter in its ongoing response to the COVID-19 pandemic August 28, 2020: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19 August 28, 2020: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines August 28, 2020: FDA Advises Health Care Providers Not to Use Gowns from Laws of Motion PPE Due to Potential Risk August 27, 2020: FDA Warns Consumers About Hand Sanitizer Packaged in Food and Drink Containers August 26, 2020: FDA Authorizes First Diagnostic Test Where Results Can Be Read Directly From Testing Card Also see the features and Emergency Use Authorization Updates below, and ongoing updates to the list of hand sanitizers consumers should not use at: www.fda.gov/handsanitizerlist

COVID-19 Updates from FDA